Brind.
  1. States in Colorado and Arizona are competing on reproductive healthcare policy.
  2. State-level restrictions are limiting the Food and Drug Administration's access to reproductive healthcare information in Arizona, prompting legal challenges.
  3. The FDA is facing actions seeking to revoke mifepristone's approval, challenging the mail-order policy, and pausing related lawsuits.

Louisiana is suing the FDA over telehealth abortions, and Liz Murrill is challenging the FDA's removal of in-person requirement.

1 report, 1 independent Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Louisiana is suing the FDA over telehealth abortions, and Liz Murrill is challenging the FDA's removal of in-person requirement.

Who's involved

What this event is mainly about
FDALouisianaLiz Murrill

Keep exploring

Part of

The FDA is facing actions seeking to revoke mifepristone's approval, challenging the mail-order policy, and pausing related lawsuits. All 1 developments

Within States in Colorado and Arizona are competing on reproductive healthcare policy.

The entities involved

Related events

Coverage

Newest first; wire copies grouped